Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carde

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|March 15, 1976
Cell-mediated immune responsiveness of patients with acute lymphocytic leukemia in remissionR K Oldham, R S Weiner, G Mathé, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with IdarubicinC Parmentier, M Finaud, M Schlumberger, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|May 12, 1983
[Primary chemotherapy in soft tissue sarcomas considered inoperable]J Rouëssé, T Le Chevalier, G Contesso, et al.
Radiation Medicine|July 1, 1983
Current trend in the treatment of Hodgkin's diseaseM Tubiana, J L Amiel, M Hayat, et al.
Leukemia & Lymphoma|October 21, 2003
Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin's lymphomasV Ribrag, S Koscielny, J M Vantelon, et al.
International Journal of Cancer|April 9, 1998
Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSFA E Bogden, J P Moreau, C Gamba-Vitalo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1985
An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary resultsJ M Cosset, F Ozanne, M Henry-Amar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3L da Costa, P Carde, J D Lumbroso, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesisE Ezan, P Carde, J Le Kerneau, et al.
Cancer Investigation|January 1, 1990
Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphomaM Hayat, M Ostronoff, E Gilles, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|March 15, 1976
Cell-mediated immune responsiveness of patients with acute lymphocytic leukemia in remissionR K Oldham, R S Weiner, G Mathé, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with IdarubicinC Parmentier, M Finaud, M Schlumberger, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|May 12, 1983
[Primary chemotherapy in soft tissue sarcomas considered inoperable]J Rouëssé, T Le Chevalier, G Contesso, et al.
Radiation Medicine|July 1, 1983
Current trend in the treatment of Hodgkin's diseaseM Tubiana, J L Amiel, M Hayat, et al.
Leukemia & Lymphoma|October 21, 2003
Phase II trial of irinotecan (CPT-11) in relapsed or refractory non-Hodgkin's lymphomasV Ribrag, S Koscielny, J M Vantelon, et al.
International Journal of Cancer|April 9, 1998
Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSFA E Bogden, J P Moreau, C Gamba-Vitalo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1985
An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary resultsJ M Cosset, F Ozanne, M Henry-Amar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Immunoscintigraphy in Hodgkin's disease and anaplastic large cell lymphomas: results in 18 patients using the iodine radiolabeled monoclonal antibody HRS-3L da Costa, P Carde, J D Lumbroso, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1994
Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesisE Ezan, P Carde, J Le Kerneau, et al.
Cancer Investigation|January 1, 1990
Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphomaM Hayat, M Ostronoff, E Gilles, et al.
Pageof 13